Birmingham, AL, United States of America

C Allen O'Dell


Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 87(Granted Patents)


Location History:

  • Fairfield, AL (US) (1979 - 1980)
  • Birmingham, AL (US) (1983 - 1988)

Company Filing History:


Years Active: 1979-1988

Loading Chart...
6 patents (USPTO):Explore Patents

Title: C Allen O'Dell: Innovator in Viral Treatment Compounds

Introduction

C Allen O'Dell is a notable inventor based in Birmingham, AL (US), recognized for his contributions to the field of medicinal chemistry. He holds a total of 6 patents, focusing primarily on compounds that have significant implications for the treatment of viral infections.

Latest Patents

Among his latest patents, O'Dell has developed carbocyclic analogues of amino and azido thymidines. These compounds are represented by specific formulas wherein X is an azido group or an amino group, and R is either hydrogen or an acyl group. They are particularly useful for treating viral infections and serve as intermediates in the production of other antiviral compounds. Another significant patent involves carbocyclic analogues of thymine nucleosides, which include compounds that inhibit the replication of DNA viruses. These compounds are also valuable as intermediates in the synthesis of other antiviral agents.

Career Highlights

Throughout his career, O'Dell has worked with reputable organizations such as Southern Research Institute and the United States Government. His work has significantly advanced the understanding and treatment of viral infections, showcasing his dedication to scientific innovation.

Collaborations

O'Dell has collaborated with esteemed colleagues, including Y Fulmer Shealy and William M Shannon, contributing to a rich environment of research and development.

Conclusion

C Allen O'Dell's innovative work in the field of viral treatment compounds has made a lasting impact on medicinal chemistry. His patents reflect a commitment to advancing healthcare solutions through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…